Abstract:Background: The essential trace element zinc is important in stabilizing pancreatic insulin secretion. Zinc not only influences the synthesis of insulin but also affects its activity. Insulin not only exerts a hypoglycemic effect but also regulates glucose and lipid metabolisms in insulin target organs. In this study, we aimed to determine changes to pancreatic β cells and insulin secretion induced by different zinc concentrations and to evaluate the effect of zinc deficiency on glucose intolerance, insulin resistance, and insulin target organs via changing insulin levels. Methods: We set up two experimental trials. In the first trial, male Sprague Dawley (SD) rats were divided into three groups. Group one (ZnC) received a standard diet, group two (ZnF) was given a zinc-free diet, and group three (ZnFC) was initially fed a zinc-free diet followed by a reversion to the standard diet. After sacrifice, we observed changes in blood parameters, including insulin, and examined alterations in pancreatic tissue using immunostaining, with focus on the localization of pancreatic β-cells. In the second trial, male SD rats were split into two groups, with one receiving a standard diet and the other a zinc-free diet. Oral glucose tolerance and insulin tolerance tests were then performed. After sacrifice, we evaluated changes in lipid and glucose metabolism within insulin target organs using quantitative polymerase chain reaction. Results: In the first trial, blood insulin levels and the area of insulin-positive staining in pancreatic β-cells decreased in the ZnF compared to the ZnC group. The ZnFC group did not show recovery in either blood insulin levels or the area of insulin-positive staining in pancreatic β-cells. In the second trial, no differences were observed in glucose tolerance or insulin resistance between the ZnC and ZnF groups. However, changes in the expression of insulin target genes were noted in the liver and adipose tissue in the ZnF group. Conclusion: We reveal that dietary zinc concentrations not only affect the concentration of insulin in the blood but also impact the localization of pancreatic β-cells involved in insulin production. Furthermore, our results suggest that changes in blood insulin levels, induced by different zinc concentrations, could cause metabolic alterations in insulin target organs such as the liver and adipose tissue. This study sheds more light on the role of zinc in insulin-regulated metabolic diseases.

Zinc Supplementation Ameliorates Er Stress and Autophagy in Liver in A Rat Model of Type 2 Diabetes Mellitus

Dietary Zinc Reduces Endoplasmic Reticulum Stress and Autophagy to Protect Against Diabetic Renal Damage in Streptozotocin-Induced Diabetic Rats

Effect of zinc supplementation on type 2 diabetes parameters and liver metallothionein expressions in Wistar rats

Effect and Mechanisms of Zinc Supplementation in Protecting Against Diabetic Cardiomyopathy in a Rat Model of Type 2 Diabetes

Effects of Zinc on Hepatic Antioxidant Systems and the Mrna Expression Levels Assayed by Cdna Microarrays in Rats

Protective Effect of Exogenous Zinc Sulfate on Liver Injury of Diabetic Rats

Zinc Treatment Prevents Type 1 Diabetes-Induced Hepatic Oxidative Damage, Endoplasmic Reticulum Stress, and Cell Death, and Even Prevents Possible Steatohepatitis in the OVE26 Mouse Model: Important Role of Metallothionein.

Antidiabetic and Pancreas-Protective Effects of Zinc Threoninate Chelate in Diabetic Rats May Be Associated with Its Antioxidative Stress Ability

The Beneficial Effects of Zinc on Diabetes-Induced Kidney Damage in Murine Rodent Model of Type 1 Diabetes Mellitus.

Zinc Chloride Enhances the Antioxidant Status, Improving the Functional and Structural Organic Disturbances in Streptozotocin-Induced Diabetes in Rats

Protective Effect of Zinc Threonine against Liver Injury in Diabetic Rats

Zinc Supplementation Alleviates Lipid and Glucose Metabolic Disorders Induced by a High Fat Diet.

EFFECTS OF ZINC OR/AND VITAMIN E SUPPLEMENTION ON BLOOD LEVELS OF NITRIC OXIDE AND ENDOTHELIN IN DIABETIC RATS

Renal Improvement by Zinc in Diabetic Mice is Associated with Glucose Metabolism Signaling Mediated by Metallothionein and Akt, but Not Akt2

Carnosine-based reversal of diabetes-associated cognitive decline via activation of the Akt/mTOR pathway and modulation of autophagy in a rat model of type 2 diabetes mellitus

Zinc supplementation partially prevents renal pathological changes in diabetic rats

Zinc deficiency affects insulin secretion and alters insulin-regulated metabolic signaling in rats

Zinc supplementation ameliorates glycoprotein components and oxidative stress changes in the lung of streptozotocin diabetic rats

Diabetes-induced Hepatic Pathogenic Damage, Inflammation, Oxidative Stress, and Insulin Resistance Was Exacerbated in Zinc Deficient Mouse Model.

Zinc supplementation protects against diabetic endothelial dysfunction via GTP cyclohydrolase 1 restoration.

The Role of Zinc in the Prevention of Diabetic Cardiomyopathy and Nephropathy